GUERBET (GBT.PA) Fundamental Analysis & Valuation
EPA:GBT • FR0000032526
Current stock price
9.95 EUR
-0.15 (-1.49%)
Last:
This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GBT.PA Profitability Analysis
1.1 Basic Checks
- GBT had negative earnings in the past year.
- In the past year GBT had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: GBT reported negative net income in multiple years.
- Each year in the past 5 years GBT had a positive operating cash flow.
1.2 Ratios
- GBT's Return On Assets of -11.65% is on the low side compared to the rest of the industry. GBT is outperformed by 70.49% of its industry peers.
- GBT has a worse Return On Equity (-40.57%) than 75.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROIC | N/A |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GBT's Operating Margin has declined in the last couple of years.
- GBT has a better Gross Margin (75.59%) than 88.52% of its industry peers.
- GBT's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for GBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% |
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
2. GBT.PA Health Analysis
2.1 Basic Checks
- GBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, GBT has about the same amount of shares outstanding.
- Compared to 5 years ago, GBT has about the same amount of shares outstanding.
- GBT has a worse debt/assets ratio than last year.
2.2 Solvency
- GBT has an Altman-Z score of 1.59. This is a bad value and indicates that GBT is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.59, GBT is doing worse than 68.85% of the companies in the same industry.
- The Debt to FCF ratio of GBT is 9.84, which is on the high side as it means it would take GBT, 9.84 years of fcf income to pay off all of its debts.
- With a Debt to FCF ratio value of 9.84, GBT perfoms like the industry average, outperforming 42.62% of the companies in the same industry.
- A Debt/Equity ratio of 1.47 is on the high side and indicates that GBT has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.47, GBT is not doing good in the industry: 78.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC6.04%
2.3 Liquidity
- A Current Ratio of 2.49 indicates that GBT has no problem at all paying its short term obligations.
- GBT has a better Current ratio (2.49) than 68.85% of its industry peers.
- A Quick Ratio of 1.27 indicates that GBT should not have too much problems paying its short term obligations.
- GBT has a Quick ratio (1.27) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 |
3. GBT.PA Growth Analysis
3.1 Past
- The earnings per share for GBT have decreased strongly by -769.32% in the last year.
- GBT shows a decrease in Revenue. In the last year, the revenue decreased by -6.50%.
- GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.00% yearly.
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
3.2 Future
- GBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 100.64% yearly.
- GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.03% yearly.
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. GBT.PA Valuation Analysis
4.1 Price/Earnings Ratio
- GBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year GBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 95.08% of the companies in the same industry are more expensive than GBT, based on the Enterprise Value to EBITDA ratio.
- GBT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GBT is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.83 | ||
| EV/EBITDA | 4.84 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as GBT's earnings are expected to grow with 100.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y275.2%
EPS Next 3Y100.64%
5. GBT.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
- The stock price of GBT dropped by -28.93% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 1.26, GBT pays a better dividend. On top of this GBT pays more dividend than 81.97% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, GBT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
GBT.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:GBT (4/21/2026, 7:00:00 PM)
9.95
-0.15 (-1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2026-03-11
Earnings (Next)04-23 2026-04-23
Inst Owners8.83%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap125.77M
Revenue(TTM)786.44M
Net Income(TTM)-108.33M
Analysts44
Price Target12.19 (22.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.81%
PT rev (3m)-8.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.86%
EPS NY rev (3m)-138.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)-8.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.16 | ||
| P/FCF | 2.83 | ||
| P/OCF | 1.55 | ||
| P/B | 0.47 | ||
| P/tB | 0.61 | ||
| EV/EBITDA | 4.84 |
EPS(TTM)-8.5
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)3.52
FCFY35.37%
OCF(TTM)6.42
OCFY64.48%
SpS62.22
BVpS21.12
TBVpS16.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% | ||
| FCFM | 5.66% |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.11%
ROCE(5y)4.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Debt/EBITDA | 5.29 | ||
| Cap/Depr | 22.55% | ||
| Cap/Sales | 4.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 109.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.59 |
F-Score4
WACC6.04%
ROIC/WACCN/A
Cap/Depr(3y)65.96%
Cap/Depr(5y)64.56%
Cap/Sales(3y)6.22%
Cap/Sales(5y)6.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-277.86%
EBIT growth 3Y-42.67%
EBIT growth 5Y-28.34%
EBIT Next Year317.55%
EBIT Next 3Y81.45%
EBIT Next 5YN/A
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y-0.16%
OCF growth 3Y38.62%
OCF growth 5Y-7.61%
GUERBET / GBT.PA Fundamental Analysis FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.
Can you provide the profitability details for GUERBET?
GUERBET (GBT.PA) has a profitability rating of 2 / 10.
Can you provide the financial health for GBT stock?
The financial health rating of GUERBET (GBT.PA) is 3 / 10.
Can you provide the expected EPS growth for GBT stock?
The Earnings per Share (EPS) of GUERBET (GBT.PA) is expected to decline by -417.31% in the next year.